Hong Kong-based private equity (PE) firm ZQ Capital has closed its first blind-pool flagship fund at $300 million to invest in the Asian growth of Western companies, the firm announced on Wednesday.
Founded in 2016 by chairman and chief investment officer (CIO) Simon Shen, ZQ Capital drew both existing and new limited partners (LPs) to invest in the fund, including institutional investors and family offices spanning North America, Europe, the Middle East, and Asia.
ZQ Capital committed $35 million of its own capital to the fund, or almost 11.7% of total commitments, according to a company statement shared with DealStreetAsia. Its commitment to the fund significantly exceeded the industry standard of 1%-5% for general partner (GP) participation, ensuring its strong financial alignment with LPs.
The new fund targets control buyouts of late-stage, small- to mid-cap companies in developed markets with strong underlying fundamentals but limited Asian presence. Acting as an operational catalyst, ZQ Capital seeks to help these Western market leaders scale by leveraging Asia’s robust supply chains, advanced technology networks, and rapidly expanding consumer markets.
The fund applies a highly selective approach to control investments in sectors where ZQ Capital’s Asia network and operational capabilities create direct and measurable impact, including consumer, education, healthcare, environmental, and finance.
The firm believes that this cross-border approach provides LPs with meaningful exposure to Asia’s growth story without the regulatory and structural complexities often associated with directly investing in the region.
“Reaching our $300 million target reflects the confidence our investors have placed in a thesis that remains differentiated in today’s market, and we are deeply grateful for their support,” said chairman and CIO Shen. “Asia continues to be one of the world’s most important economic regions, yet many leading businesses from developed markets are still only beginning to realise the opportunities it offers. With the fund now fully capitalised, we look forward to partnering with exceptional management teams to create long-term value for our investors.”
The final close came more than one year after ZQ Capital held the first close at over $180 million in March 2025. In an interview with DealStreetAsia in September of the same year, Shen said that ZQ Capital planned to invest in 5-10 control or buyout transactions of mostly smaller-cap, developed-market companies with an enterprise value (EV) of sub-$500 million through the flagship fund.
Its first portfolio company is UK-based Allergy Therapeutics.
“We drive value from Asia, but our underlying asset is a solid cash flow-positive, developed-market business that has a defensive risk profile compared to directly investing in Asia’s developing markets,” said Shen in the interview.
With investment professionals located in Hong Kong, Shanghai, Singapore, and Zurich, ZQ Capital expects to announce new investments through the fund in the coming months. To date, the firm has executed over $1 billion of transactions.
